Stay updated on Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page.

Latest updates to the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page
- Check3 days agoChange DetectedA site-wide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.SummaryDifference1%

- Check10 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check17 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1 on an otherwise unchanged 403 error page.SummaryDifference0.2%

- Check38 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the previous study record content. This blocks access to the study details, sponsor and investigator information, locations, and related data.SummaryDifference18%

- Check59 days agoChange DetectedRevision: v3.6.6 replaces the previous Revision: v3.6.5 on the study page, signaling a minor update to the version history of the record.SummaryDifference0.1%

- Check81 days agoChange DetectedVersion tag updated from v3.6.4 to v3.6.5 on the page, signaling a follow-up update to the record. This is a minor metadata change and does not modify the study data or content shown.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page.